Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- Check5 days agoChange DetectedThe history now includes a new Revision: v3.3.4 and removes Revision: v3.3.3, reflecting a minor administrative update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedResults Posted including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status (Revision: v3.3.3, 2025-12-19). Previous entry 'Results Submitted' and 'HHS Vulnerability Disclosure' removed (Revision: v3.3.2, 2025-10-28).SummaryDifference0.5%

- Check55 days agoChange DetectedThe Record History now shows revision v3.3.2 with a Returned date of 2025-11-21 and a QC status of Not Concluded. New sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other document sections were added, and the Study Status was updated.SummaryDifference0.5%

- Check62 days agoChange DetectedThe history shows a new 'Results Submitted' status and removes the 'No Results Posted' notice, indicating that trial results have been submitted.SummaryDifference0.3%

- Check76 days agoChange DetectedA new 'Study Status' entry was added to the record history on 2025-10-28, corresponding to version 83 listed on 2025-10-27.SummaryDifference0.2%

- Check98 days agoChange DetectedThe study title changed from “Patients 6 to 17 Years of Age” to “Participants 6 to 17 Years of Age,” the date updated from 2025-01-29 to 2025-10-06, and new metadata sections (Study Identification, Status, Design, Arms and Interventions, Outcome Measures, Eligibility) were added.SummaryDifference2%

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.